Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1996 Aug;61(2):131–137. doi: 10.1136/jnnp.61.2.131

Neuroepidemiology of amyotrophic lateral sclerosis: clues to aetiology and pathogenesis.

G C Román 1
PMCID: PMC1073984  PMID: 8708678

Full text

PDF
133

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Appel S. H., Smith R. G., Engelhardt J. I., Stefani E. Evidence for autoimmunity in amyotrophic lateral sclerosis. J Neurol Sci. 1994 Jul;124 (Suppl):14–19. doi: 10.1016/0022-510x(94)90171-6. [DOI] [PubMed] [Google Scholar]
  2. Araki S., Iwahashi Y., Kuroiwa Y. Epidemiological study of amyotrophic lateral sclerosis and allied disorders in the Kii Peninsula (Japan). J Neurol Sci. 1967 Mar-Apr;4(2):279–287. doi: 10.1016/0022-510x(67)90106-2. [DOI] [PubMed] [Google Scholar]
  3. Bensimon G., Lacomblez L., Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med. 1994 Mar 3;330(9):585–591. doi: 10.1056/NEJM199403033300901. [DOI] [PubMed] [Google Scholar]
  4. Bharucha N. E., Schoenberg B. S., Raven R. H., Pickle L. W., Byar D. P., Mason T. J. Geographic distribution of motor neuron disease and correlation with possible etiologic factors. Neurology. 1983 Jul;33(7):911–915. doi: 10.1212/wnl.33.7.911. [DOI] [PubMed] [Google Scholar]
  5. Brown R. H., Jr Superoxide dismutase and familial amyotrophic lateral sclerosis: new insights into mechanisms and treatments. Ann Neurol. 1996 Feb;39(2):145–146. doi: 10.1002/ana.410390202. [DOI] [PubMed] [Google Scholar]
  6. Chancellor A. M., Swingler R. J., Fraser H., Clarke J. A., Warlow C. P. Utility of Scottish morbidity and mortality data for epidemiological studies of motor neuron disease. J Epidemiol Community Health. 1993 Apr;47(2):116–120. doi: 10.1136/jech.47.2.116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chancellor A. M., Warlow C. P. Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950. J Neurol Neurosurg Psychiatry. 1992 Dec;55(12):1106–1115. doi: 10.1136/jnnp.55.12.1106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chaudhuri K. R., Crump S., al-Sarraj S., Anderson V., Cavanagh J., Leigh P. N. The validation of El Escorial criteria for the diagnosis of amyotrophic lateral sclerosis: a clinicopathological study. J Neurol Sci. 1995 May;129 (Suppl):11–12. doi: 10.1016/0022-510x(95)00050-c. [DOI] [PubMed] [Google Scholar]
  9. Chiò A., Magnani C., Oddenino E., Tolardo G., Schiffer D. Accuracy of death certificate diagnosis of amyotrophic lateral sclerosis. J Epidemiol Community Health. 1992 Oct;46(5):517–518. doi: 10.1136/jech.46.5.517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chiò A., Magnani C., Schiffer D. Amyotrophic lateral sclerosis mortality in Italy, 1958 to 1987: a cross-sectional and cohort study. Neurology. 1993 May;43(5):927–930. doi: 10.1212/wnl.43.5.927. [DOI] [PubMed] [Google Scholar]
  11. Chió A., Meineri P., Tribolo A., Schiffer D. Risk factors in motor neuron disease: a case-control study. Neuroepidemiology. 1991;10(4):174–184. doi: 10.1159/000110267. [DOI] [PubMed] [Google Scholar]
  12. Elian M., Dean G. The changing mortality from motor neurone disease and multiple sclerosis in England and Wales and the Republic of Ireland. Neuroepidemiology. 1992;11(4-6):236–243. doi: 10.1159/000110936. [DOI] [PubMed] [Google Scholar]
  13. Ferrante P., Westarp M. E., Mancuso R., Puricelli S., Westarp M. P., Mini M., Caputo D., Zuffolato M. R. HTLV tax-rex DNA and antibodies in idiopathic amyotrophic lateral sclerosis. J Neurol Sci. 1995 May;129 (Suppl):140–144. doi: 10.1016/0022-510x(95)00086-h. [DOI] [PubMed] [Google Scholar]
  14. Gajdusek D. C., Salazar A. M. Amyotrophic lateral sclerosis and parkinsonian syndromes in high incidence among the Auyu and Jakai people of West New Guinea. Neurology. 1982 Feb;32(2):107–126. doi: 10.1212/wnl.32.2.107. [DOI] [PubMed] [Google Scholar]
  15. Garruto R. M., Shankar S. K., Yanagihara R., Salazar A. M., Amyx H. L., Gajdusek D. C. Low-calcium, high-aluminum diet-induced motor neuron pathology in cynomolgus monkeys. Acta Neuropathol. 1989;78(2):210–219. doi: 10.1007/BF00688211. [DOI] [PubMed] [Google Scholar]
  16. Garruto R. M., Yanagihara R., Gajdusek D. C. Disappearance of high-incidence amyotrophic lateral sclerosis and parkinsonism-dementia on Guam. Neurology. 1985 Feb;35(2):193–198. doi: 10.1212/wnl.35.2.193. [DOI] [PubMed] [Google Scholar]
  17. Giagheddu M., Puggioni G., Masala C., Biancu F., Pirari G., Piras M. R., Rachele M. G. Epidemiologic study of amyotrophic lateral sclerosis in Sardinia, Italy. Acta Neurol Scand. 1983 Dec;68(6):394–404. doi: 10.1111/j.1600-0404.1983.tb04849.x. [DOI] [PubMed] [Google Scholar]
  18. Granieri E., Carreras M., Tola R., Paolino E., Tralli G., Eleopra R., Serra G. Motor neuron disease in the province of Ferrara, Italy, in 1964-1982. Neurology. 1988 Oct;38(10):1604–1608. doi: 10.1212/wnl.38.10.1604. [DOI] [PubMed] [Google Scholar]
  19. Gunnarsson L. G., Bodin L., Söderfeldt B., Axelson O. A case-control study of motor neurone disease: its relation to heritability, and occupational exposures, particularly to solvents. Br J Ind Med. 1992 Nov;49(11):791–798. doi: 10.1136/oem.49.11.791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Gunnarsson L. G., Lindberg G., Söderfelt B., Axelson O. The mortality of motor neuron disease in Sweden. Arch Neurol. 1990 Jan;47(1):42–46. doi: 10.1001/archneur.1990.00530010050018. [DOI] [PubMed] [Google Scholar]
  21. Gurney M. E., Cutting F. B., Zhai P., Doble A., Taylor C. P., Andrus P. K., Hall E. D. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol. 1996 Feb;39(2):147–157. doi: 10.1002/ana.410390203. [DOI] [PubMed] [Google Scholar]
  22. Heafield M. T., Fearn S., Steventon G. B., Waring R. H., Williams A. C., Sturman S. G. Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson's and Alzheimer's disease. Neurosci Lett. 1990 Mar 2;110(1-2):216–220. doi: 10.1016/0304-3940(90)90814-p. [DOI] [PubMed] [Google Scholar]
  23. Hentati A., Bejaoui K., Pericak-Vance M. A., Hentati F., Speer M. C., Hung W. Y., Figlewicz D. A., Haines J., Rimmler J., Ben Hamida C. Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q33-q35. Nat Genet. 1994 Jul;7(3):425–428. doi: 10.1038/ng0794-425. [DOI] [PubMed] [Google Scholar]
  24. Hochberg F. H., Bryan J. A., 2nd, Whelan M. A. Letter: Clustering of amyotrophic lateral sclerosis. Lancet. 1974 Jan 5;1(7845):34–34. doi: 10.1016/s0140-6736(74)93037-2. [DOI] [PubMed] [Google Scholar]
  25. Hoffman P. M., Brody J. A. The reliability of death certificate reporting for amyotrophic lateral sclerosis. J Chronic Dis. 1971 Jun;24(1):5–8. doi: 10.1016/0021-9681(71)90053-1. [DOI] [PubMed] [Google Scholar]
  26. Holloway S. M., Emery A. E. The epidemiology of motor neuron disease in Scotland. Muscle Nerve. 1982 Feb;5(2):131–133. doi: 10.1002/mus.880050209. [DOI] [PubMed] [Google Scholar]
  27. Hyser C. L., Kissel J. T., Mendell J. R. Three cases of amyotrophic lateral sclerosis in a common occupational environment. J Neurol. 1987 Aug;234(6):443–444. doi: 10.1007/BF00314096. [DOI] [PubMed] [Google Scholar]
  28. Jokelainen M. The epidemiology of amyotrophic lateral sclerosis in Finland. A study based on the death certificates of 421 patients. J Neurol Sci. 1976 Sep;29(1):55–63. doi: 10.1016/0022-510x(76)90080-0. [DOI] [PubMed] [Google Scholar]
  29. KURLAND L. T., MULDER D. W. Epidemiologic investigations of amyotrophic lateral sclerosis. 2. Familial aggregations indicative of dominant inheritance. I. Neurology. 1955 Mar;5(3):182–196. doi: 10.1212/wnl.5.3.182. [DOI] [PubMed] [Google Scholar]
  30. KURLAND L. T., MULDER D. W. Epidemiologic investigations of amyotrophic lateral sclerosis. I. Preliminary report on geographic distribution, with special reference to the Mariana Islands, including clinical and pathologic observations. Neurology. 1954 May;4(5):355–378. doi: 10.1212/wnl.4.5.355. [DOI] [PubMed] [Google Scholar]
  31. Kisby G. E., Ellison M., Spencer P. S. Content of the neurotoxins cycasin (methylazoxymethanol beta-D-glucoside) and BMAA (beta-N-methylamino-L-alanine) in cycad flour prepared by Guam Chamorros. Neurology. 1992 Jul;42(7):1336–1340. doi: 10.1212/wnl.42.7.1336. [DOI] [PubMed] [Google Scholar]
  32. Kurland L. T., Radhakrishnan K., Smith G. E., Armon C., Nemetz P. N. Mechanical trauma as a risk factor in classic amyotrophic lateral sclerosis: lack of epidemiologic evidence. J Neurol Sci. 1992 Dec;113(2):133–143. doi: 10.1016/0022-510x(92)90241-c. [DOI] [PubMed] [Google Scholar]
  33. Leone M., Chandra V., Schoenberg B. S. Motor neuron disease in the United States, 1971 and 1973-1978: patterns of mortality and associated conditions at the time of death. Neurology. 1987 Aug;37(8):1339–1343. doi: 10.1212/wnl.37.8.1339. [DOI] [PubMed] [Google Scholar]
  34. Leveugle B., Spik G., Perl D. P., Bouras C., Fillit H. M., Hof P. R. The iron-binding protein lactotransferrin is present in pathologic lesions in a variety of neurodegenerative disorders: a comparative immunohistochemical analysis. Brain Res. 1994 Jul 4;650(1):20–31. doi: 10.1016/0006-8993(94)90202-x. [DOI] [PubMed] [Google Scholar]
  35. Melmed C., Krieger C. A cluster of amyotrophic lateral sclerosis. Arch Neurol. 1982 Sep;39(9):595–596. doi: 10.1001/archneur.1982.00510210065018. [DOI] [PubMed] [Google Scholar]
  36. Neilson S., Gunnarsson L. G., Robinson I. Rising mortality from motor neurone disease in Sweden 1961-1990: the relative role of increased population life expectancy and environmental factors. Acta Neurol Scand. 1994 Sep;90(3):150–159. doi: 10.1111/j.1600-0404.1994.tb02698.x. [DOI] [PubMed] [Google Scholar]
  37. Neilson S., Robinson I., Alperovitch A. Rising amyotrophic lateral sclerosis mortality in France 1968-1990: increased life expectancy and inter-disease competition as an explanation. J Neurol. 1994 Jun;241(7):448–455. doi: 10.1007/BF00900964. [DOI] [PubMed] [Google Scholar]
  38. Neilson S., Robinson I., Hunter M. Longitudinal Gompertzian analysis of ALS mortality in England and Wales, 1963-1989: estimates of susceptibility in the general population. Mech Ageing Dev. 1992 Jun;64(1-2):201–216. doi: 10.1016/0047-6374(92)90107-o. [DOI] [PubMed] [Google Scholar]
  39. Neilson S., Robinson I., Kondo K. A new analysis of mortality from motor neurone disease in Japan, 1950-1990: rise and fall in the postwar years. J Neurol Sci. 1993 Jul;117(1-2):46–53. doi: 10.1016/0022-510x(93)90153-p. [DOI] [PubMed] [Google Scholar]
  40. Neilson S., Robinson I., Nymoen E. H. Longitudinal analysis of amyotrophic lateral sclerosis mortality in Norway, 1966-1989: evidence for a susceptible subpopulation. J Neurol Sci. 1994 Apr;122(2):148–154. doi: 10.1016/0022-510x(94)90292-5. [DOI] [PubMed] [Google Scholar]
  41. O'Malley F., Dean G., Elian M. Multiple sclerosis and motor neurone disease: survival and how certified after death. J Epidemiol Community Health. 1987 Mar;41(1):14–17. doi: 10.1136/jech.41.1.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Okumura H., Kurland L. T., Waring S. C. Amyotrophic lateral sclerosis and polio: is there an association? Ann N Y Acad Sci. 1995 May 25;753:245–256. doi: 10.1111/j.1749-6632.1995.tb27551.x. [DOI] [PubMed] [Google Scholar]
  43. Perl D. P., Gajdusek D. C., Garruto R. M., Yanagihara R. T., Gibbs C. J. Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam. Science. 1982 Sep 10;217(4564):1053–1055. doi: 10.1126/science.7112111. [DOI] [PubMed] [Google Scholar]
  44. Plaitakis A., Caroscio J. T. Abnormal glutamate metabolism in amyotrophic lateral sclerosis. Ann Neurol. 1987 Nov;22(5):575–579. doi: 10.1002/ana.410220503. [DOI] [PubMed] [Google Scholar]
  45. Proctor S. P., Feldman R. G., Wolf P. A., Brent B., Wartenberg D. A perceived cluster of amyotrophic lateral sclerosis cases in a Massachusetts community. Neuroepidemiology. 1992;11(4-6):277–281. doi: 10.1159/000110941. [DOI] [PubMed] [Google Scholar]
  46. Reed D. M., Brody J. A. Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam, 1945-1972. I. Descriptive epidemiology. Am J Epidemiol. 1975 Apr;101(4):287–301. doi: 10.1093/oxfordjournals.aje.a112097. [DOI] [PubMed] [Google Scholar]
  47. Reed D. M., Torres J. M., Brody J. A. Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam, 1945-1972. II. Familial and genetic studies. Am J Epidemiol. 1975 Apr;101(4):302–310. doi: 10.1093/oxfordjournals.aje.a112098. [DOI] [PubMed] [Google Scholar]
  48. Reed D., Labarthe D., Chen K. M., Stallones R. A cohort study of amyotrophic lateral sclerosis and parkinsonism-dementia on Guam and Rota. Am J Epidemiol. 1987 Jan;125(1):92–100. doi: 10.1093/oxfordjournals.aje.a114515. [DOI] [PubMed] [Google Scholar]
  49. Riggs J. E. Longitudinal Gompertzian analysis of amyotrophic lateral sclerosis mortality in the U.S., 1977-1986: evidence for an inherently susceptible population subset. Mech Ageing Dev. 1990 Sep;55(3):207–220. doi: 10.1016/0047-6374(90)90149-a. [DOI] [PubMed] [Google Scholar]
  50. Rothstein J. D., Martin L. J., Kuncl R. W. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med. 1992 May 28;326(22):1464–1468. doi: 10.1056/NEJM199205283262204. [DOI] [PubMed] [Google Scholar]
  51. Rothstein J. D., Tsai G., Kuncl R. W., Clawson L., Cornblath D. R., Drachman D. B., Pestronk A., Stauch B. L., Coyle J. T. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol. 1990 Jul;28(1):18–25. doi: 10.1002/ana.410280106. [DOI] [PubMed] [Google Scholar]
  52. Rowland L. P. Amyotrophic lateral sclerosis with paraproteins and autoantibodies. Adv Neurol. 1995;68:93–111. [PubMed] [Google Scholar]
  53. Sanders M. Clustering of amyotrophic lateral sclerosis. JAMA. 1980 Aug 1;244(5):435–435. [PubMed] [Google Scholar]
  54. Shaw P. J. Excitotoxicity and motor neurone disease: a review of the evidence. J Neurol Sci. 1994 Jul;124 (Suppl):6–13. doi: 10.1016/0022-510x(94)90170-8. [DOI] [PubMed] [Google Scholar]
  55. Spencer P. S., Kisby G. E., Ross S. M., Roy D. N., Hugon J., Ludolph A. C., Nunn P. B. Guam ALS-PDC: possible causes. Science. 1993 Nov 5;262(5135):825–826. doi: 10.1126/science.8235599. [DOI] [PubMed] [Google Scholar]
  56. Spencer P. S., Nunn P. B., Hugon J., Ludolph A. C., Ross S. M., Roy D. N., Robertson R. C. Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science. 1987 Jul 31;237(4814):517–522. doi: 10.1126/science.3603037. [DOI] [PubMed] [Google Scholar]
  57. Steele J. C., Guzman T. Observations about amyotrophic lateral sclerosis and the parkinsonism-dementia complex of Guam with regard to epidemiology and etiology. Can J Neurol Sci. 1987 Aug;14(3 Suppl):358–362. doi: 10.1017/s0317167100037744. [DOI] [PubMed] [Google Scholar]
  58. Strong M. J., Garruto R. M. Chronic aluminum-induced motor neuron degeneration: clinical, neuropathological and molecular biological aspects. Can J Neurol Sci. 1991 Aug;18(3 Suppl):428–431. doi: 10.1017/s0317167100032601. [DOI] [PubMed] [Google Scholar]
  59. Swingler R. J., Fraser H., Warlow C. P. Motor neuron disease and polio in Scotland. J Neurol Neurosurg Psychiatry. 1992 Dec;55(12):1116–1120. doi: 10.1136/jnnp.55.12.1116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Westarp M. E., Ferrante P., Perron H., Bartmann P., Kornhuber H. H. Sporadic ALS/MND: a global neurodegeneration with retroviral involvement? J Neurol Sci. 1995 May;129 (Suppl):145–147. doi: 10.1016/0022-510x(95)00087-i. [DOI] [PubMed] [Google Scholar]
  61. Wiedau-Pazos M., Goto J. J., Rabizadeh S., Gralla E. B., Roe J. A., Lee M. K., Valentine J. S., Bredesen D. E. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science. 1996 Jan 26;271(5248):515–518. doi: 10.1126/science.271.5248.515. [DOI] [PubMed] [Google Scholar]
  62. Zhang Z. X., Anderson D. W., Mantel N., Román G. C. Motor neuron disease on Guam: geographic and familial occurrence, 1956-85. Acta Neurol Scand. 1996 Jul;94(1):51–59. doi: 10.1111/j.1600-0404.1996.tb00039.x. [DOI] [PubMed] [Google Scholar]
  63. Zhang Z. X., Anderson D. W., Mantel N., Román G. C. Motor neuron disease on Guam: temporal occurrence, 1941-85. Acta Neurol Scand. 1995 Oct;92(4):299–307. doi: 10.1111/j.1600-0404.1995.tb00133.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES